Posted by Michael Wonder on 18 Oct 2017
Cancer drug prices rising far faster than inflation
18 October 2017 - The prices of injectable cancer drugs - even older medicines around since the 1990s - are increasing at a rate far higher than inflation, researchers report in the Journal of Clinical Oncology.
The study, led by Dr. Daniel Goldstein of Emory University in Atlanta, looked at 24 injectable cancer drugs approved since 1996 and found the average increase was 25% over eight years. After inflation, the average increase was 18%.
The prices of some drugs were going up by an average of 6% or more per year when the inflation rate was just under 1.1%.
